News

Filter

Current filters:

Galsulfase

1 to 9 of 13 results

BioMarin's 1st-qtr beats analyst expectations

12-05-2008

The USA's BioMarin Pharmaceutical beat Wall Street expectations and swung to a first-quarter 2008 profit…

AldurazymeGalsulfaseGenzymeLaronidaseNaglazyme

AnGes launches BioMarin's Naglazyme in Japan

21-04-2008

Japan's AnGes MG has launched Naglazyme (galsulfase) for patients with the genetic disease mucopolysaccharidosis…

GalsulfaseNaglazyme

BioMarin/AnGes' Naglazyme approved in Japan

07-04-2008

BioMarin and fellow USA-based AnGes MG have received approval for Naglazyme (galsulfase) from the Japanese…

GalsulfaseNaglazyme

Humira and Naglazyme recommended for approval in Japan

10-03-2008

The first Subcommittee on Drugs at the Drug and Food Sanitary Council of Japan's Ministry of Health,…

Abbott LaboratoriesadalimumabGalsulfaseHumiraNaglazyme

BioMarin partner submits Naglazyme BLA in Japan

20-08-2007

California, USA-based BioMarin Pharmaceutical says that AnGes MG, its marketing and distribution partner…

GalsulfaseNaglazyme

BioMarin's Naglazyme approved in Europe

06-02-2006

The USA's BioMarin Pharmaceutical says that the European Commission has granted marketing authorization…

GalsulfaseNaglazyme

1 to 9 of 13 results

Back to top